author-photo

B. Idzior-Waluś

Jagiellonian University Medical College

28

Papers

48

Citations

Citation Trend

Filter By

Papers (22) Sort By

Journal Conference Others

Apolipoproteins and renal function in patients with type 2 diabetes and NAFLD

2021 Atherosclerosis
Show All
- Source
- Cite
- Save
Citations (0)
Serum pentraxin 3 concentration in patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease

2019 Polish archives of internal medicine
Show All
- Source
- Cite
- Save
Citations (4)
Correlates of pentraxin 3 serum concentration in men and women with type 2 diabetes

2019 Innate Immunity
Show All
- Source
- Cite
- Save
Citations (1)
Pentraxin 3 in patients with type 2 diabetes and nonalcoholic fatty liver disease: a promising treatment target for glucagon-like peptide-1 receptor agonists. Authors' reply

2019 Polish archives of internal medicine
Show All
- Source
- Cite
- Save
Citations (0)
Circulating PCSK9 in Statin-Treated Patients with Type 2 Diabetes Mellitus (T2DM)

2018 Diabetes
Show All
- Source
- Cite
- Save
Citations (0)
Fibroblast growth factor 21 serum concentrations in patients with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (DM2).

2018 Atherosclerosis
Show All
- Source
- Cite
- Save
Citations (0)
Pentraxin 3 concentration is positively associated with apo C3 and abdominal obesity in men with type 2 diabetes

2017 Atherosclerosis
Show All
- Source
- Cite
- Save
Citations (0)
Pentraxin 3 concentration in patients with type 2 diabetes mellitus and NAFLD

2017 Atherosclerosis
Show All
- Source
- Cite
- Save
Citations (1)
Prognostic Value of Proinflammatory Markers in Patients After Kidney Transplantation in Relation to the Presence of Diabetes

2016 Transplantation Proceedings
Show All
- Source
- Cite
- Save
Citations (5)
Evaluation of the association of plasma pentraxin 3 levels with type 2 diabetes and diabetic nephropathy in patients with renal failure

2016 Atherosclerosis
Show All
- Source
- Cite
- Save
Citations (0)